Gastroesophageal Reflux Disease (GERD) & Acid Peptic Disease

Editor's Choice

Sleep Aid May Lead to More Acid Reflux Exposure

The sleep-inducing drug zolpidem may help patients with gastroesophageal reflux sleep through reflux events, increasing their acid exposure, according to research published in the September issue of Clinical Gastroenterology and Hepatology.

LATEST ARTICLES

PPI's efficacy and safety questioned for pediatric GERD

The effectiveness and safety of proton pump inhibitors for pediatric gastroesophageal reflux disease are far from proven, according to a new systematic review.

New Tool: Rx Adherence Predictor

Now you can determine in advance the likelihood of a patient filling and staying on their medications. This tool can support your ability to prioritize and target patients who may benefit from counseling about the importance of maintaining your prescribed drug regimen.

A strategy for GERD and Barrett's esophagus

Chronic gastroesophageal reflux disease in older patients is a risk factor for Barrett's esophagus, and anyone potentially at risk for this predominant precursor to esophageal adenocarcinoma should be referred to a gastroenterologist.

Preferential formulary listing of a proton-pump inhibitor (PPI): Compliance with policy in a Canadian military population

In 2003, the Canadian Forces (CF) drug benefit plan used preferential listing to control costs associated with proton pump inhibitors (PPIs); however, significant expenditures for nonbenefit PPIs continued. A database review was thus conducted to explain this anomalous usage pattern. This study provides further information regarding the effectiveness of preferred listing as a cost-saving measure, noting that adherence to such policies may be less than projected.

Antacid sales top $10 billion annually

Information on OTC indigestion remedies that pharmacists can use to brief patients